MicroRNA-3200-3p targeting CAMK2A modulates the proliferation and metastasis of glioma in vitro

Bioengineered. 2022 Mar;13(3):7785-7797. doi: 10.1080/21655979.2022.2048995.

Abstract

MicroRNA (miRNA) is strongly interrelated with the pathogenesis of glioma. However, its potential biological effect and underlying mechanism of miR-3200-3p in human glioma remain elusive. In the current study, we checked the level of miR-3200-3p in different glioma cells. Then, its biological functions on glioma cell proliferation metastasis was investigated using the miR-3200-3p mimic and inhibitor. The direct target of miR-3200-3p was tested in these cells. Results demonstrated that miR-3200-3p is remarkably downregulated in human glioma cells. The relative level of miR-3200-3p is strongly associated with biological features, including proliferation, colony formation, and metastasis. Additionally, Ca2+/calmodulin dependent kinase 2a (CAMK2A) might be the direct target gene of miR-3200-3p, and CAMK2A overexpression reversed the anticancer roles of miR-3200-3p on glioma cellular function. Importantly, these results further showed that miR-3200-3p downregulated the proliferation and metastasis by suppressing the expression of CAMK2A, thus regulating the Ras/Raf/MEK/ERK pathway. This study provided provided insights into the biological role of miR-3200-3p, which might function as a potential biomarker in glioma therapy.

Keywords: CAMK2A; Glioma; metastasis; miR-3200-3p; proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Glioma* / metabolism
  • Humans
  • MAP Kinase Signaling System
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism

Substances

  • MIRN3200 microRNA, human
  • MicroRNAs
  • CAMK2A protein, human
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2

Grants and funding

The study was supported by the Health Commission Project of Jiangxi Province, China (202130628).